Number of patients | 10 |
Age (years), mean(range) | 77.4 (39–81) |
Gender | |
Male | 4(40) |
Female | 6 (60) |
Cancer Stage (UICC, 8th ed.), N (%) | |
I | 1 (10) |
II | 0 (0) |
III | 2 (20) |
IV | 7 (70) |
Histology, N (%) | |
Renal cell carcinoma | 4 (40) |
Prostate cancer | 4 (40) |
Urothelial cancer | 2 (20) |
Course of COVID-19, N (%): | |
Mild | 0 (0) |
Mechanical ventilation | 2 (20) |
Noncritical care hospitalization | 4 (40) |
Critical care hospitalization (oxygen support) | 4 (40) |
Duration of COVID-19, median (days) | 28.8 |
Death as a COVID-19 disease outcome, N (%) | 4 (40) |